◆ TICKERBASE · US STOCK FINANCIAL DATA LIBRARY

HomeAll stocks › MIRM

Mirum Pharmaceuticals, Inc. (MIRM) Financial History

4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.

Healthcare · Biotechnology · DATA UPDATED 2026-07-21

Mirum Pharmaceuticals, Inc. (MIRM) operates in the Biotechnology industry and is headquartered in Foster City, United States with about 418 employees. Its market capitalization is roughly $7 billion. In the fiscal year ended 2025-12-31, MIRM reported $521M in revenue and ($23M) in net income.

Mirum Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel therapies for debilitating rare and orphan diseases.

Interactive charts & full statements → Open the MIRM valuation workbench →

MIRM Revenue & Earnings History — Annual Income Statement

Income statement2025-12-312024-12-312023-12-312022-12-312021-12-31
Total Revenue$521M$337M$186M$77M
Gross Profit$421M$255M$139M$65M
Operating Income (EBIT)($22M)($88M)($109M)($131M)
Net Income($23M)($88M)($163M)($136M)

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

MIRM Quarterly Revenue & Earnings — Last 8 Quarters

Quarterly income statement2026-03-312025-12-312025-09-302025-06-302025-03-312024-12-31
Total Revenue$160M$149M$133M$128M$112M
Gross Profit$131M$121M$108M$104M$89M
Operating Income (EBIT)($63M)($5M)$3M($5M)($10M)
Net Income($790M)($6M)$3M($6M)($15M)

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

MIRM Free Cash Flow History

Cash flow2025-12-312024-12-312023-12-312022-12-312021-12-31
Dividends Paid$0M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

MIRM Balance Sheet History

Balance sheet2025-12-312024-12-312023-12-312022-12-312021-12-31
Total Assets$843M$671M$647M$353M
Total Liabilities$528M$445M$398M$211M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive MIRM viewer.

Other Companies in Biotechnology

← MIRAAll stocksMIST →

About TickerBase · Data methodology & sources

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.